NDC product
DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE
NDC 70069-051 · Somerset Therapeutics, LLC
Key facts
| Product NDC | 70069-051 |
|---|---|
| Proprietary name | DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE |
| Nonproprietary name | DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE |
| Substances | DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE |
| Dosage form | SOLUTION |
| Route | OPHTHALMIC |
| Labeler | Somerset Therapeutics, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA207523 |
| Pharmacologic classes | Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC] |
| Marketing start | Jun 25, 2019 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: